<prompt> Cobimetinib is approved for treatment of?BCCMelanomaSquamous cell carcinomaVitiligo  <response>: Cobimetinib is approved for RX of melanoma in patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation, in conjunction with Vemurafenib. Cobimetinib - Reversible inhibitor of mitogen-activated protein kinase MAPKextracellular signal regulated kinase. 